当前位置: 首页 > 期刊 > 《中国医学创新》 > 2012年第3期
编号:13183673
思密达与去甲肾上腺素联合治疗新生儿消化道出血临床研究
http://www.100md.com 2012年1月25日 洪艳 姜赤秋
第1页

    参见附件。

     【摘要】 目的 探讨思密达与去甲肾上腺素联合治疗新生儿消化道出血的临床疗效。方法 将66例消化道出血的新生患儿随机分为治疗组34例和对照组32例。对照组给予常规治疗,治疗组在常规治疗基础上加用思密达和去甲肾上腺素鼻饲。结果 治疗组止血效果明显优于对照组(P<0.05),平均止血时间也短于对照组(P<0.05)。结论 思密达与去甲肾上腺素联合治疗新生儿消化道出血具有显著疗效。

    【关键词】 去甲肾上腺素; 思密达; 消化道出血; 新生儿

    Clinical study of smecta ahd norepinephrine on newborn Gastrointestinal Hemorrhage HONG Yan,JIANG Chi-qiu. Zhongshan Hospital,Wuhan 430030,China

    【Abstract】 Objective To discuss the clinical effect of a smecta and norepinephrine on newborn Gastrointestinal Hemorrhage.Methods 66 newborns with Gastrointestinal Hemorrhage were randomly divided into treatment group and control group.Control group was treated with conventional treatment.On the basis of control group,treatment group was added smecta ahd norepinephrine with nasal feeding.Results The curative effect in treatment group was obviously better than that in control group(P<0.01), and the average time of stanch bleeding was obviously shorter than that in control group(P<0 ......

您现在查看是摘要介绍页,详见PDF附件